Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04645966
What this trial is testing

A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants

Who this might be right for
Meningococcal Vaccine
Pfizer 326
Testing effectiveness (Phase 2)Study completedNCT00415051
What this trial is testing

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine

Who this might be right for
Rift Valley Fever
U.S. Army Medical Research and Development Command 20
Early research (Phase 1)Looking for participantsNCT07004244
What this trial is testing

Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies

Who this might be right for
Malignant Tumors
Sichuan University 20
Early research (Phase 1)UnknownNCT05047445
What this trial is testing

A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection

Who this might be right for
COVID-19
Scancell Ltd 80
Large-scale testing (Phase 3)Study completedNCT01738477
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 165
Large-scale testing (Phase 3)Study completedNCT01229371
What this trial is testing

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers

Who this might be right for
Influenza
Crucell Holland BV 440
Testing effectiveness (Phase 2)UnknownNCT01718834
What this trial is testing

Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection

Who this might be right for
Vaccine Overdose of Undetermined Intent
National Liver Institute, Egypt 50
Post-approval studies (Phase 4)Ended earlyNCT02409095
What this trial is testing

Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants

Who this might be right for
Immune Response to DTP-HB-Hib Vaccine
Serum Institute of India Pvt. Ltd. 211
Early research (Phase 1)Study completedNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Large-scale testing (Phase 3)Study completedNCT00500357
What this trial is testing

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects

Who this might be right for
Vaccines, Pneumococcal Conjugate Vaccine
Wyeth is now a wholly owned subsidiary of Pfizer 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT06549530
What this trial is testing

Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections

Who this might be right for
Monkeypox (Mpox)
Bavarian Nordic 460
Large-scale testing (Phase 3)Study completedNCT06011200
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT01161264
What this trial is testing

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects

Who this might be right for
Seasonal Influenza
Novartis Vaccines 126
Testing effectiveness (Phase 2)Study completedNCT05710224
What this trial is testing

Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)

Who this might be right for
Dengue
Butantan Institute 1,364
Early research (Phase 1)Study completedNCT01373879
What this trial is testing

AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic Area

Who this might be right for
Malaria
University of Oxford 52
Large-scale testing (Phase 3)Study completedNCT00552279
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 805
Early research (Phase 1)Study completedNCT00090896
What this trial is testing

CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT03614533
What this trial is testing

Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso

Who this might be right for
Typhoid
University of Maryland, Baltimore 251
Testing effectiveness (Phase 2)Study completedNCT02018458
What this trial is testing

Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer

Who this might be right for
Breast Cancer
Baylor Research Institute 10
Early research (Phase 1)Study completedNCT04144348
What this trial is testing

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

Who this might be right for
Human Metapneumovirus and Human Parainfluenza Infection
ModernaTX, Inc. 51
Next Page